Development, Implementation and Evaluation of the Impact of a Guideline in Clinical Practise for Cardiovascular Risk
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The aim of this study is to evaluate the impact of a clinical guideline in cardiovascular risk, with a local adaptation model of the existing guidelines in clinical practise at present, of each of the different cardiovascular risk factors, and the implementation strategy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2004
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 4, 2011
CompletedFirst Posted
Study publicly available on registry
January 5, 2011
CompletedJanuary 5, 2011
January 1, 2011
2.2 years
January 4, 2011
January 4, 2011
Conditions
Study Arms (2)
Implementation
EXPERIMENTALdissemination
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- patients whose health cards showed them to belong to the studied health area
You may not qualify if:
- Clinical history have not opened in the health center or this one is empty
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gerencia de Atención Primaria del área 2
Madrid, Madrid, 28009, Spain
Related Publications (1)
Rodriguez-Salvanes F, Novella B, Fernandez Luque MJ, Sanchez-Gomez LM, Ruiz-Diaz L, Sanchez-Alcalde R, Sierra-Garcia B, Mayayo S, Ruiz-Lopez M, Loeches P, Lopez-Gonzalez J, Gonzalez-Gamarra A; SIRVA2 group. Efficacy of a strategy for implementing a guideline for the control of cardiovascular risk in a primary healthcare setting: the SIRVA2 study a controlled, blinded community intervention trial randomised by clusters. BMC Fam Pract. 2011 Apr 19;12:21. doi: 10.1186/1471-2296-12-21.
PMID: 21504570DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Blanca Novella, MD. pHD
Gerencia de Atención Primaria del área 2
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
January 4, 2011
First Posted
January 5, 2011
Study Start
January 1, 2004
Primary Completion
April 1, 2006
Study Completion
July 1, 2010
Last Updated
January 5, 2011
Record last verified: 2011-01